NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups
This article was originally published in The Gray Sheet
Executive Summary
The National Institutes of Health expects to publish by year-end a "best practices" document for the licensing of genomic inventions
You may also be interested in...
Genomic Patent Exclusivity Tackled By NIH “Best Practices” Draft Guidance
NIH is floating a three-page draft guidance on best practices for the licensing of genomic inventions
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.